An Ex Vivo Toe Model Used to Assess Applicators for the Iontophoretic Ungual Delivery of Terbinafine

Levels of terbinafine in plasma, stratum corneum, dermis/epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks.

Jan Faergemann, H Zehender, J. Denouël et al. · Acta Dermato Venereologica · 1993 · 173 citations · Full text

Pharmacy, Dermatology, Pharmacology +6

In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs

Yoichi Kobayashi, Tsunehisa Komatsu, Machiko Sumi et al. · European Journal of Pharmaceutical Sciences · 2004 · 103 citations

Pharmacy, Pharmaceutics, Pharmacology +16

Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis

Anroop B. Nair, Hyun D. Kim, Bireswar Chakraborty et al. · Journal of Pharmaceutical Sciences · 2009 · 76 citations

Pharmacy, Pharmaceutics, Pharmacology +11

Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses

Y.M. CLAYTON · British Journal of Dermatology · 1994 · 76 citations

Medicine, Dermatology, Antimicrobial Pharmacology +16

Determination of terbinafine in nail samples during systemic treatment for onychomycoses

P.J. Dykes, R Thomas, A.Y. Finlay · British Journal of Dermatology · 2006 · 65 citations

Medicine, Dermatology, Pharmaceutical Analysis +15